tetano
Editor, Senior Moderator
irc Heart Fail
. 2020 Jun 5.
doi: 10.1161/CIRCHEARTFAILURE.120.007220. Online ahead of print.
Approach to Acute Cardiovascular Complications in COVID-19 Infection
Lauren S Ranard[SUP] 1 [/SUP], Justin A Fried[SUP] 1 [/SUP], Marwah Abdalla[SUP] 1 [/SUP], D Edmund Anstey[SUP] 1 [/SUP], Raymond C Givens[SUP] 1 [/SUP], Deepa Kumaraiah[SUP] 1 [/SUP], Susheel K Kodali[SUP] 2 [/SUP], Koji Takeda[SUP] 3 [/SUP], Dimitri Karmpaliotis[SUP] 2 [/SUP], LeRoy E Rabbani[SUP] 1 [/SUP], Gabriel Sayer[SUP] 1 [/SUP], Ajay J Kirtane[SUP] 4 [/SUP], Martin B Leon[SUP] 2 [/SUP], Allan Schwartz[SUP] 1 [/SUP], Nir Uriel[SUP] 1 [/SUP], Amirali Masoumi[SUP] 1 [/SUP]
Affiliations
Abstract
The novel coronavirus disease 2019, otherwise known as COVID-19, is a global pandemic with primary respiratory manifestations in those who are symptomatic. It has spread to more than 187 countries with a rapidly growing number of affected patients. Underlying cardiovascular disease is associated with more severe manifestations of COVID-19 and higher rates of mortality. COVID-19 can have both primary (arrhythmias, myocardial infarction, myocarditis) and secondary (myocardial injury/biomarker elevation, heart failure) cardiac involvement. In severe cases, profound circulatory failure can result. This review discusses the presentation and management of patients with severe cardiac complications of COVID-19 disease, with an emphasis on a "Heart-Lung" team approach in patient management. Furthermore, it focuses on the use of and indications for acute mechanical circulatory support in cardiogenic and/or mixed shock.
. 2020 Jun 5.
doi: 10.1161/CIRCHEARTFAILURE.120.007220. Online ahead of print.
Approach to Acute Cardiovascular Complications in COVID-19 Infection
Lauren S Ranard[SUP] 1 [/SUP], Justin A Fried[SUP] 1 [/SUP], Marwah Abdalla[SUP] 1 [/SUP], D Edmund Anstey[SUP] 1 [/SUP], Raymond C Givens[SUP] 1 [/SUP], Deepa Kumaraiah[SUP] 1 [/SUP], Susheel K Kodali[SUP] 2 [/SUP], Koji Takeda[SUP] 3 [/SUP], Dimitri Karmpaliotis[SUP] 2 [/SUP], LeRoy E Rabbani[SUP] 1 [/SUP], Gabriel Sayer[SUP] 1 [/SUP], Ajay J Kirtane[SUP] 4 [/SUP], Martin B Leon[SUP] 2 [/SUP], Allan Schwartz[SUP] 1 [/SUP], Nir Uriel[SUP] 1 [/SUP], Amirali Masoumi[SUP] 1 [/SUP]
Affiliations
- PMID: 32500721
- DOI: 10.1161/CIRCHEARTFAILURE.120.007220
Abstract
The novel coronavirus disease 2019, otherwise known as COVID-19, is a global pandemic with primary respiratory manifestations in those who are symptomatic. It has spread to more than 187 countries with a rapidly growing number of affected patients. Underlying cardiovascular disease is associated with more severe manifestations of COVID-19 and higher rates of mortality. COVID-19 can have both primary (arrhythmias, myocardial infarction, myocarditis) and secondary (myocardial injury/biomarker elevation, heart failure) cardiac involvement. In severe cases, profound circulatory failure can result. This review discusses the presentation and management of patients with severe cardiac complications of COVID-19 disease, with an emphasis on a "Heart-Lung" team approach in patient management. Furthermore, it focuses on the use of and indications for acute mechanical circulatory support in cardiogenic and/or mixed shock.